Atrial Functional Mitral Regurgitation (#AFMR): 📍increasingly recognized subtype of #MR 📍caused by #LA remodelling & mitral annular dilation w/o primary valve disease or #LV dysfunction 📍Epidemiology: ~40–65% of FMR, often in the elderly👵🧓, female👩, #HFpEF, #AFib

@kp_rommel received the research award of the RobertMüllerStiftung paying tribute to his academic and clinical mentors, honoured to be one of those 🤩 @IngoEitel @thiele_holger !

Determinants of Right Heart Hemodynamic Derangement in Patients with and Without Tricuspid Regurgitation @GParati22 @denisamuraru @GodinoCosmo @FudimMarat @a_sorropago @jeanlucvachiery @CaravitaSergio @michetomaselli @lpbadano #AHAJournals https://t.co/bXTCJqa3s7

Join leading experts at HFA Congress 2025 for this CME accredited session: "Interventions for heart failure: mitral, tricuspid, and atrial shunt therapies" Topics include: - The unmet need for structural interventions in HF - Clinical outcomes and strategies in atrial shunt

🧵Renal Denervation (RDN) for Hypertension – A meta-analysis of 12 sham-controlled RCTs in @ehjopen https://t.co/d1G916H0Xi @jennifer_rymer @RVSwaminathanMD @manesh_patelMD @FudimMarat

#Interventional_Heart_Failure 1⃣What it is 2⃣How you train for it 3⃣Where it is heading Charting the Course for Careers in Interventional Heart Failure: Training, Challenges, and Future Directions https://t.co/GT6Rh8LC5t @MyJSCAI @RichardChengMD @MAlvarezVillela @NavinKapur4

🔥 #THT2025 is in full swing! The room is packed with attendees diving into the latest breakthroughs in #heartfailure research and treatments. Exciting sessions, cutting-edge insights — this is where #innovation happens! 🫀🚀 #CardioX #CardioTwitter #CardioEd #CardioResearch

Join the revolution at #THT2025 on Tuesday Feb 11 2025 with exciting breakfast and lunch symposia on #Cardiometabolic disease and #AtrialShunts in #HFpEF 6:30 am for the early birds 12:15 pm for the rest Get your runners ready (no heels, I hear!)

Renal Denervation (RDN) has emerged as the third pillar of HTN treatment, alongside meds & lifestyle. Given its role in reducing SNS overdrive, could it be a game-changer for HF? #HREV explores the evidence & future directions. ( https://t.co/o5u4uSaXJN) @PhilippLurz @FudimMarat

@PhilippLurz @KP_Kresoja @FudimMarat @Franzi_Koppe @RoschSeb @BurkhoffMd @guilbon @EZancanaroMD @KardiologieHH @CaravitaSergio @crfheart @PCRonline @RyanTedfordMD @CSIcongress @MarcoMetra @vonBardelebenRS @HFpEF @jgranadacrf @FelixMahfoud #THT2025 #CardioTwitter

🚨 #HFpEF remains biggest unmet need in CV medicine! ❓Can #InterventionalHF + #ShuntTherapy live up to the promise? ⚡RA "vortex" flow might be 🔑 to understanding #RightHeartfailure with shunting! 👀intriguing narrative and stunning MRI visuals by @HEARTinMagnet below👇

In this episode of IMPact podcast, listen to @EZancanaroMD @jgrapsa @alessia_gimelli @KP_Kresoja @kp_rommel , discuss "Tricuspid regurgitation and heart failure: the fate of treated vs. untreated cohort in the percutaneous Era" https://t.co/xy91MGHBcM #Spotify -->

Transcatheter Edge-to-Edge Repair for Tricuspid Regurgitation https://t.co/n2vBE83tty @PhilippLurz @JGrapsa @Cosyns @CHU

🌟Great way to start at #PCRLV Main Arena: Innovation for transcatheter tricuspid interventions @azeemlatib @didier_tchetche @PhilippLurz @hahn_rt @modine_thomas @PCRonline 🎯Live TTVR case with Evoque system 🎯 Recorded TTVR case with Cardiovalve presented by @RodrigoEstvez1

🤔#TTEER or #TTVR for #TR-related right-#heartfailure❓ Matched analysis by @gu_asc1 @TCTConference : 🎯TTVR: better TR ⬇️ 🎯No differences in 1-y death/HFH (~10%)‼️ Lots of ❓remain, but in absence of RCT - big 🦶forward 👀 out for the manuscript soon. #TCT2024 #LuxValve

Now: Live from Mainz‼️@TCTconference #TCT2024 #MTEER in Atrial-MR w/ @PhilippLurz @EZancanaroMD #TRuf + #TGössler @samdawkins @BadhwarVinay @crfheart

Exciting insights, great discussion at #TCT2024 disruptive imaging session on right-#heartfailure 1) PAPi refines prognostic value of TAPSE/PASP in #TTEER by @guilbon-#EuroTR-team 2) Liver-ECV on #MRI could be new marker of systemic congestion by @JoaoLCavalcante-team @crfheart

🏅 The CRF SET-10: Global Rankings are here! CRF proudly unveils the top 10 institutions advancing interventional cardiovascular medicine at #TCT2024. These global leaders are driving innovation and excellence in heart care. 🌍❤️ Congrats to the #SET10 for pushing the

We discussed this observation on #CardioTwitter: several noted that administering a heparin bolus the ER (100 units/Kg, not max 4,000), rather than waiting until the cath lab, improves TIMI flow by the time the patient reaches the cath lab. This is now supported by an RCT!

✨ A unique moment at #TCT2024: Jeffrey W. Moses receives a lifetime achievement award, celebrating his extraordinary impact in interventional cardiology. His touching speech honored his family, his father, and his team. A beautiful celebration of his legacy, hosted by @CRFHeart.